Early Post-operative Stimulated Serum Thyroglobulin: Role in Preventing Unnecessary Radioactive Iodine Treatment in Low to Intermediate Risk Papillary Thyroid Cancer
Authors:
- Havva SezerHSHavva Sezer
- Dilek YazıcıDYDilek Yazıcı
- Tarık TerzioğluTTTarık Terzioğlu
- Serdar TezelmanSTSerdar Tezelman
- Hande Bulut CanbazHCHande Bulut Canbaz
- Mehmet Onur DemirkolMDMehmet Onur Demirkol
- Yersu KapranYKYersu Kapran
- Bülent ÇolakoğluBÇBülent Çolakoğlu
- Eda Nur ÇilingiroğluEÇEda Nur Çilingiroğlu
- Faruk AlagölFAFaruk Alagöl
- 13 June 2023
- journal article
- research article
- Published by SAGE Publications in The American Surgeon™
- Vol. 89 (12) , 5996-6004
Abstract
Aim: The aims of the study are to evaluate the predictive value of early post-operative stimulated thyroglobulin (sTg) analysis on the recurrence risk, and to define a cut-off value that is related to recurrence risk in low to intermediate risk papillary thyroid cancer (PTC). Methods: This retrospective cohort study included individuals who were diagnosed with PTC aged 18 years or older and had been operated by experienced surgeons of a tertiary university hospital between the years 2011 and 2021. The American Thyroid Association thyroid cancer guidelines version 2015 was used as the risk stratification system. Early sTg measurement obtained at 3-4 weeks after surgery when TSH >30 µIU/mL. Data was collected from the hospital database. A total of 328 patients who had post-operative early sTg values with negative anti-Tg antibodies were included. Results: The median age was 44 years. Of the 328 patients, 223 (68%) were women. The median tumor diameter was 11 mm. One hundred ninety-one patients (58.2%) had low risk and 137 (41.8%) had intermediate risk for recurrent disease. Of the 328 patients, 4.0% had recurrent disease. In multivariate Cox regression, post-operative early sTg value [OR: 1.070 (1.038-1.116), P = .000], and the pre-operative malign cytology [OR: 1.483 (1.080-2.245), P = .042] were independent risk factors for recurrence. On the ROC curve analysis, the cut-off value of early sTg was 4.1 ng/mL for those with recurrent disease. Conclusion: This study demonstrated that early sTg could predict recurrent disease in patients with low to intermediate risk PTC. A cut-off of 4.1 ng/mL was identified with a high negative predictive value.Keywords
This publication has 25 references indexed in Scilit:
- Thyroglobulin measurement by highly sensitive assays: focus on laboratory challengesClinical Chemistry and Laboratory Medicine (CCLM), 2014
- Postoperative-stimulated serum thyroglobulin measured at the time of 131I ablation is useful for the prediction of disease status in patients with differentiated thyroid carcinomaSurgery, 2013
- Papillary Thyroid Cancer: Time Course of Recurrences During Postsurgery SurveillanceThe Journal of Clinical Endocrinology & Metabolism, 2013
- Postoperative Stimulated Thyroglobulin of Less Than 1 ng/mL as a Criterion to Spare Low-Risk Patients with Papillary Thyroid Cancer from Radioactive Iodine AblationThyroid®, 2012
- Combination of Initial Stimulation Thyroglobulins and Staging System by Revised ATA Guidelines Can Elaborately Discriminate Prognosis of Patients With Differentiated Thyroid Carcinoma After High-Dose Remnant AblationClinical Nuclear Medicine, 2012
- Factors determining the persistence or recurrence of well-differentiated thyroid cancer treated by thyroidectomy and/or radioiodine in the Boston, Massachusetts area: A retrospective chart reviewThyroid Research, 2011
- Estimating Risk of Recurrence in Differentiated Thyroid Cancer After Total Thyroidectomy and Radioactive Iodine Remnant Ablation: Using Response to Therapy Variables to Modify the Initial Risk Estimates Predicted by the New American Thyroid Association Staging SystemThyroid®, 2010
- Postsurgery serum thyroglobulin disappearance kinetic in patients with differentiated thyroid carcinomaHead & Neck, 2010
- Application of post‐surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low‐risk papillary thyroid carcinomaHead & Neck, 2010
- Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancerJournal of Endocrinological Investigation, 2002